Gilead Stock Plummets on HIV Funding
This is a news story, published by Investor's Business Daily, that relates primarily to Gilead Sciences' news.
stocks trading & speculation news
For more stocks trading & speculation news, you can click here:
more stocks trading & speculation newsInvestor's Business Daily news
For more news from Investor's Business Daily, you can click here:
more news from Investor's Business DailyAbout the Otherweb
Otherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best business news, entertainment news, world news, and much more. If you like stocks trading & speculation news, you might also like this article about
Gilead stock. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest Gilead Sciences news, HIV treatments news, stocks trading & speculation news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
GileadInvestor's Business Daily
•Business
Business & Economics
Gilead Sciences stock slides on reports federal funding for HIV prevention could be cut

71% Informative
Gilead Sciences' HIV treatments accounted for 68% of its revenue last year .
Last year , the company generated north of $19.61 billion in sales of its HIV treatments.
The company doesn't separate out which sales came from pre-exposure prophylaxis, or PrEP.
VR Score
69
Informative language
69
Neutral language
57
Article tone
formal
Language
English
Language complexity
28
Offensive language
possibly offensive
Hate speech
not hateful
Attention-grabbing headline
detected
Known propaganda techniques
not detected
Time-value
short-lived
External references
4
Source diversity
3
Affiliate links
no affiliate links